Gland Pharma (NSE:GLAND) Short Ratio


NSE:GLAND Gland Pharma Ltd NSE:GLAND
86 GF Score
Price ₹2,479.40
GF Value ₹2,138.83
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Gland Pharma Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:GLAND
86GF Score
Gland Pharma Ltd NSE:GLAND
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gland Pharma (NSE:GLAND) Overvalued in 2026?

Based on GuruFocus' analysis, Gland Pharma stock appears to be overvalued. The current stock price of ₹2,479.40 is trading 15.9% above its estimated GF Value™ of ₹2,138.83. GuruFocus considers Gland Pharma to be Modestly Overvalued.

Key valuation signals for NSE:GLAND:

  • Short Ratio:
  • GF Value™: ₹2,138.83 vs. price of ₹2,479.40 (15.9% above fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the NSE:GLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gland Pharma Business Description

Other Exchanges 543245:India
Address TSIIC, Phase - IV, Plot No. 11 and 84, Pashamylaram (V), Patancheru M, Sangareddy District, Hyderabad, TG, IND, 502307
Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, and Daptomycin Injection, among others. The group is also involved in a vast range of therapeutic categories, including Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarials, Cardiology, and more, to Hormones and related Drugs, Fertility Supplements, and GnRH Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA, and the rest from Europe, India, Canada, Australia, and other regions.
86GF Score

Get the complete analysis for NSE:GLAND

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,479.40
Price
₹2,138.83
GF Value